Alessa Therapeutics, Inc., a clinical-stage drug development company pioneering an innovative and proprietary localized drug delivery technology for the early interception of cancer and other diseases, announced today that Dr. Pamela Munster has been named Chief Executive officer succeeding John Maroney who has served as acting CEO since inception.
July 5, 2022
· 2 min read